Skip to main content

Published locations for FDA study suggests dabigatran’s pros outweigh cons

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA study suggests dabigatran’s pros outweigh cons

User login

  • Reset your password
  • /content/fda-study-suggests-dabigatrans-pros-outweigh-cons
  • /hematology-oncology/article/185929/thrombosis/fda-study-suggests-dabigatrans-pros-outweigh-cons
  • /hematologytimes/article/185929/thrombosis/fda-study-suggests-dabigatrans-pros-outweigh-cons